Dr. Tang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-726-5050Fax+1 617-724-1122
Education & Training
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2017 - 2020
- Harvard T.H.Chan School of Public HealthMPH, Biostats and Epi, 2016 - 2017
- Zhejiang Medical UniversityClass of 2015
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MA State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease.Mengyao Tang, Mario Luca Morieri, Sahir Kalim, Alessandro Doria
Journal of the American Society of Nephrology. 2025-01-07 - Clinical implications of mineralocorticoid receptor overactivation.Christopher El Mouhayyar, Monika Chhikara, Mengyao Tang, Sagar U Nigwekar
Clinical Kidney Journal. 2025-01-01 - In Reply to "Considerations on Potential Modifiers of Glycated Albumin Levels in Patients With CKD".Mengyao Tang, Sahir Kalim
American Journal of Kidney Diseases. 2024-10-01
Press Mentions
- Glycemic Variability in Diabetes Ups AKI, CKD RisksSeptember 28th, 2023
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: